USINA PHARM
0553.961.456 · rovalta.com · 24/09/2026
USINA PHARM
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOUSINA PHARM is a Private limited company incorporated in 2014. Its main activity is: Forging, pressing, stamping and roll-forming of metal; powder metallurgy. Its registered office is in Quévy. It employs on average 1,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0553.961.456
- Incorporation
- 20/06/2014
- Legal form
- Private limited company
- Registered office
- Rue des Carrières(HAV) 15
7041 Quévy · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,3 ETP
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 783,5 k € | +9.8% | 713,8 k € | -7.6% | 772,2 k € | +19.8% | 644,7 k € | +16.1% | 555,4 k € |
| EBITDA | 700 k € | +20.6% | 580,5 k € | -10.3% | 646,8 k € | +17.6% | 549,9 k € | +18.5% | 464,2 k € |
| Operating result | 491,9 k € | +34.4% | 365,9 k € | -15.1% | 430,8 k € | +13.9% | 378,1 k € | +8.3% | 349 k € |
| Net result | 349,6 k € | +45.3% | 240,6 k € | -16.8% | 289,1 k € | -8.4% | 315,6 k € | +30.9% | 241,1 k € |
| Balance sheet | |||||||||
| Equity | 2 M € | +27.1% | 1,6 M € | +17.8% | 1,3 M € | +5.3% | 1,3 M € | +16.3% | 1,1 M € |
| Total assets | 3,2 M € | +8.4% | 3 M € | +3.5% | 2,9 M € | -4.5% | 3 M € | +22.0% | 2,5 M € |
| Cash | 789,8 k € | -25.0% | 1,1 M € | +48.7% | 708,3 k € | -14.3% | 826,4 k € | -13.6% | 956,5 k € |
| Debts | 1,2 M € | -12.9% | 1,4 M € | -8.5% | 1,5 M € | -12.4% | 1,7 M € | +26.5% | 1,4 M € |
| Other | |||||||||
| Workforce | 1,3 ETP | -45.8% | 2,4 ETP | 0.0% | 2,4 ETP | +20.0% | 2,0 ETP | – | |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/08/2026 | 26/08/2025 | 30/08/2024 | 29/08/2023 | 31/08/2022 | 31/08/2021 |
| General meeting | 24/06/2026 | 25/06/2025 | 26/06/2024 | 28/06/2023 | 29/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 24/06/2026 | 27/08/2026 | French | |
| Abridged model | 31/12/2024 | 25/06/2025 | 26/08/2025 | French | |
| Abridged model | 31/12/2023 | 26/06/2024 | 30/08/2024 | French | |
| Abridged model | 31/12/2022 | 28/06/2023 | 29/08/2023 | French | |
| Micro model | 31/12/2021 | 29/06/2022 | 31/08/2022 | French | |
| Micro model | 31/12/2020 | 30/06/2021 | 31/08/2021 | French | |
| Micro model | 31/12/2019 | 24/06/2020 | 30/09/2020 | French | |
| Micro model | 31/12/2018 | 26/06/2019 | 29/08/2019 | French | |
| Micro model | 31/12/2017 | 27/06/2018 | 28/08/2018 | French | |
| Micro model | 31/12/2016 | 28/06/2017 | 30/08/2017 | French | |
| Abridged model | 31/12/2015 | 29/06/2016 | 30/08/2016 | French | |
| Abridged model | 31/12/2014 | 24/06/2015 | 27/08/2015 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025349,6 k €↑
- 2024Annual accounts 2024240,6 k €↓
- 2023Annual accounts 2023289,1 k €↓
- 2022Annual accounts 2022315,6 k €↑
- 2021Annual accounts 2021241,1 k €↓
- 2020Annual accounts 2020311,3 k €↑
- 2019Annual accounts 2019165,6 k €↓
- 2018Annual accounts 2018218,5 k €↑
- 2017Annual accounts 2017114,9 k €↑
- 2016Annual accounts 201626,5 k €↓
- 2015Annual accounts 201588,4 k €↑
- 2014Annual accounts 201433,5 k €
- 20/06/2014IncorporationPrivate limited company